ObjectiveTo provide the referencefor the guideline development and revision in China, we analyzed the composition of personnel who participated in developing Chinese clinical practice guidelines (CPGs)published in 2017. MethodsCNKI, WanFang Data, CBM and Google scholar were electronically searched to collect Chinese CPGs published from January 1st to December 31st, 2017. Two researchers independently screened literatures, extracted data of interest, such as composition and distribution of personnel, and analyzed the composition of personnel with Microsoft excel 2013. ResultsA total of 54 guidelines were included, and the majority of which are for treatment. Among which, 49 were developed by the associations accounting for 90.7%. Twenty-four (44.4%) guidelines reported the geographical distribution and unit ownership of the guideline developers, such as hospitals, schools, institutions (academies, institutes, laboratories, nursing homes, etc.). Almost all of the guidelines were developed by the cooperative work of experts from multidisciplinary clinical setting, 15 (27.8%) of which mentioned the participation of the methodologist. Among which, 13 (24.1%) of them involved literature retrieval experts, 2 (3.7%) of them involved epidemiologists, 2 (3.7%) of them involved evidence-based medicine experts, 1 (1.9%) of them involved statistical expert. Three of which mentioned external peer review. None of them has systematic review team. ConclusionIn China, the CPG formulation/revision organization is still not considering the importance of multidisciplinary collaboration, methodology researchers, and patients’ participation and external evaluation teams, which will affect the quality, practicability and maneuverability of CPG. We propose that multidisciplinary cooperation should be strengthened in the future while developing CPG, giving full consideration to the importance of medical personnel and the values of patients, and promoting the application of methodology.